mars 31 Kaer Labs and the covid-19 crisis Our resources can be made available to research labs for the fight against SARS Cov2. Do not hesitate to contact us if we can help you.
mars 2 NIR-II imaging at the LIOPA platform In vivo NIR-II fluorescence at the LIOPA, Paris: the advantage of longer wavelengths for in vivo small animal optical imaging
févr. 11 Survey: development of imaging Agents for fluorescence Image guided surgery Answer this 5-question survey and get an idea of how other researchers design their own molecules!
janv. 24 Réseau Entreprendre Laureate Kaer Labs selected by Réseau Entreprendre Atlantique for a 2-year mentorship with a highly experienced leader
19 déc. 2019 New publication: bimodal PET/Fluo agent targeting pancreatic cancer in preclinical model Publication in Journal of Medicianl Chemistry: development of a bimodal PET/Fluo agent targeting PDAC pancreatic tumors using the KIS
16 sept. 2019 Kaer Labs selected in Novapuls Promo #3! Kaer Labs is proud to join the startups WeData, Ives, Launchr, Robank Hood, My Bacchus and Teodym for the third edition of its venture ac...
1 juil. 2019 ANR DualmAb The project DualmAb has been selected by the Agence Nationale de la Recherche (ANR) and will be funded from 2020.
18 juin 2019 NETVA Program Kaer Labs is proud to belong to the list of Deep Tech startups selected for the New Technology Venture Accelerator program managed by the...
26 mars 2019 Special Mention of the Jury for Kaer Labs at Forum Labo Kaer Labs has received a Special Mention of the Jury at the occasion of the annual conference Forum Labo in Paris. The company is rewarde...
1 nov. 2018 Kaer Labs supported by Atlanpole At the occasion of its official inception, Kaer Labs is glad to thank Atlanpole for its support and guidance. Atlanpole has supported the...
